TWD 101.5
(-1.93%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -51.59 Million TWD | -412.05% |
2022 | 16.53 Million TWD | 143.48% |
2021 | -38.02 Million TWD | -1268.26% |
2020 | -2.77 Million TWD | 86.48% |
2019 | -20.55 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -6.2 Million TWD | 62.74% |
2024 Q2 | -6.2 Million TWD | 0.0% |
2023 Q2 | -9.13 Million TWD | 0.0% |
2023 Q4 | -16.66 Million TWD | 0.0% |
2023 Q1 | -9.13 Million TWD | -255.77% |
2023 FY | -51.59 Million TWD | -412.05% |
2023 Q3 | -16.66 Million TWD | -82.5% |
2022 Q3 | 5.86 Million TWD | 0.0% |
2022 FY | 16.53 Million TWD | 143.48% |
2022 Q4 | 5.86 Million TWD | 0.0% |
2021 FY | -38.02 Million TWD | -1268.26% |
2020 FY | -2.77 Million TWD | 86.48% |
2019 FY | -20.55 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
BIONET Corp. | 78.39 Million TWD | 165.811% |
DIVA Laboratories, Ltd. | 73.61 Million TWD | 170.086% |
Genetics Generation Advancement Corp. | 28.56 Million TWD | 280.623% |
Welgene Biotech Co.,Ltd. | -2.64 Million TWD | -1848.452% |
TFBS Bioscience Inc. | 4.9 Million TWD | 1151.029% |